Ozempic and GLP-1s Show Promise in Protecting Brain Health and Reducing Stroke Risk
TL;DR Summary
Recent studies presented at SNIS suggest that GLP-1 receptor agonists like Ozempic, commonly used for diabetes and obesity, may have neuroprotective effects, including reducing stroke risk and improving survival and recovery outcomes after stroke and brain hemorrhages.
- Protecting Your Brain? Scientists Identify New Health Benefit of Ozempic SciTechDaily
- GLP-1s Could Protect Against Neurodegeneration, Study Finds BioSpace
- Semaglutide emerges as contender in cerebrovascular disease management The Pharma Letter
- Weight Loss Drugs Like Ozempic May Also Protect Against Dementia, Stroke, and Even Death health.com
- Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity Endocrinology Advisor
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 4 min read
Condensed
94%
640 → 37 words
Want the full story? Read the original article
Read on SciTechDaily